Aurobindo Pharma Hits 52-Week High on Twin USFDA Approvals
April 20, 2026April 20, 2026 Shares of Aurobindo Pharma Limited touched a 52-week high of Rs 1,396.60 on the BSE on 20 April, rising 0.79% from the previous close of Rs 1,385.65, after the company secured two product approvals from the U.S. Food and Drug Administration. The pharma firm…